Laura Zanotti

3.7k total citations
76 papers, 1.9k citations indexed

About

Laura Zanotti is a scholar working on Oncology, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Laura Zanotti has authored 76 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 25 papers in Molecular Biology and 20 papers in Reproductive Medicine. Recurrent topics in Laura Zanotti's work include Ovarian cancer diagnosis and treatment (14 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Cancer Cells and Metastasis (7 papers). Laura Zanotti is often cited by papers focused on Ovarian cancer diagnosis and treatment (14 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Cancer Cells and Metastasis (7 papers). Laura Zanotti collaborates with scholars based in Italy, United States and Sweden. Laura Zanotti's co-authors include Antonella Ravaggi, Eliana Bignotti, Chiara Romani, Elisabetta Bandiera, Renata Tassi, Franco Odicino, Sërgio Pecorelli, Daniele Generali, Stefano Calza and Germana Tognon and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Laura Zanotti

75 papers receiving 1.9k citations

Peers

Laura Zanotti
Gustavo C. Rodriguez United States
P.H.B. Willemse Netherlands
Christine Walsh United States
Chad M. Michener United States
Karin Leunen Belgium
Laura Zanotti
Citations per year, relative to Laura Zanotti Laura Zanotti (= 1×) peers Ilan Bruchim

Countries citing papers authored by Laura Zanotti

Since Specialization
Citations

This map shows the geographic impact of Laura Zanotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Zanotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Zanotti more than expected).

Fields of papers citing papers by Laura Zanotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Zanotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Zanotti. The network helps show where Laura Zanotti may publish in the future.

Co-authorship network of co-authors of Laura Zanotti

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Zanotti. A scholar is included among the top collaborators of Laura Zanotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Zanotti. Laura Zanotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ravaggi, Antonella, Cássia T. Bergamaschi, Laura Zanotti, et al.. (2024). Circulating Serum Micro-RNA as Non-Invasive Diagnostic Biomarkers of Endometriosis. Biomedicines. 12(10). 2393–2393. 4 indexed citations
2.
Zanotti, Laura, et al.. (2023). Optimizing the first-line treatment for metastatic colorectal cancer. Frontiers in Oncology. 13. 1246716–1246716. 5 indexed citations
3.
Romani, Chiara, Elisabetta Grillo, Marco Silvestri, et al.. (2021). The Claudin-Low Subtype of High-Grade Serous Ovarian Carcinoma Exhibits Stem Cell Features. Cancers. 13(4). 906–906. 7 indexed citations
4.
Todeschini, Paola, Elisa Salviato, Chiara Romani, et al.. (2021). Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer. Cancers. 13(13). 3358–3358. 16 indexed citations
5.
Ardighieri, Laura, Francesco Missale, Mattia Bugatti, et al.. (2021). Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes. Frontiers in Immunology. 12. 690201–690201. 42 indexed citations
6.
Romani, Chiara, Elisa Salviato, Alberto Paderno, et al.. (2021). Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma. Theranostics. 11(6). 2987–2999. 44 indexed citations
7.
Romani, Chiara, Valentina Zizioli, Marco Silvestri, et al.. (2020). Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients. Frontiers in Oncology. 10. 1287–1287. 11 indexed citations
8.
Pellegrini, Camilla, Marta Columbaro, Elisa Schena, et al.. (2019). Altered adipocyte differentiation and unbalanced autophagy in type 2 Familial Partial Lipodystrophy: an in vitro and in vivo study of adipose tissue browning. Experimental & Molecular Medicine. 51(8). 1–17. 31 indexed citations
9.
Prochilo, Tiziana, et al.. (2018). Hair Loss Prevention by a Scalp Cooling Device in Early Breast Cancer Patients: The Poliambulanza Preliminary Experience. Reviews on Recent Clinical Trials. 14(1). 66–71. 7 indexed citations
10.
Corona, Silvia Paola, Andrea Ravelli, Daniele Cretella, et al.. (2017). CDK4/6 inhibitors in HER2-positive breast cancer. Critical Reviews in Oncology/Hematology. 112. 208–214. 37 indexed citations
11.
Bonetta, Alberto, Giandomenico Roviello, Daniele Generali, et al.. (2017). Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma. Research and Reports in Urology. Volume 9. 65–69. 5 indexed citations
12.
Bandiera, Elisabetta, Paola Todeschini, Chiara Romani, et al.. (2016). The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines. Oncology Letters. 12(4). 2493–2500. 15 indexed citations
13.
Roviello, Giandomenico, Manuela Milani, Maria Rosa Cappelletti, et al.. (2016). A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-Negative Breast Cancers. Clinical Breast Cancer. 16(3). e57–e59. 4 indexed citations
14.
Petrioli, Roberto, Giandomenico Roviello, Laura Zanotti, et al.. (2016). Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 102. 82–88. 28 indexed citations
15.
Generali, Daniele, Mara Ardine, Carla Strina, et al.. (2015). Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?. JNCI Monographs. 2015(51). 32–35. 6 indexed citations
16.
Bignotti, Eliana, Renata Tassi, Stefano Calza, et al.. (2013). Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. Journal of Translational Medicine. 11(1). 162–162. 4 indexed citations
17.
Ruggeri, Giuseppina, Elisabetta Bandiera, Laura Zanotti, et al.. (2011). HE4 and epithelial ovarian cancer: Comparison and clinical evaluation of two immunoassays and a combination algorithm. Clinica Chimica Acta. 412(15-16). 1447–1453. 95 indexed citations
18.
Tassi, Renata, Stefano Calza, Antonella Ravaggi, et al.. (2009). Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence. BMC Cancer. 9(1). 253–253. 16 indexed citations
19.
Bandiera, Elisabetta, Laura Zanotti, Eliana Bignotti, et al.. (2009). Human Kallikrein 5. International Journal of Gynecological Cancer. 19(6). 1015–1021. 14 indexed citations
20.
Borsani, Elisa, Stefano Salgarello, Alessandra Stacchiotti, et al.. (2007). Altered immunolocalization of heat-shock proteins in human peri-implant gingiva. Acta Histochemica. 109(3). 221–227. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026